MTOR and cancer: Interestingly, not only proton pump inhibitors but also mTOR inhibitors such as rapamycin or rapamycin analogues (rapalogs), used in the treatment of cancer [68, 69] have shown to decrease lactate production by tumor cells increasing extracellular pH [70].